I

Inter Pharma PCL
SET:IP

Watchlist Manager
Inter Pharma PCL
SET:IP
Watchlist
Price: 3.78 THB -4.55% Market Closed
Market Cap: 2.3B THB
Have any thoughts about
Inter Pharma PCL?
Write Note

Income Statement

Earnings Waterfall
Inter Pharma PCL

Revenue
1.8B THB
Cost of Revenue
-1.1B THB
Gross Profit
653m THB
Operating Expenses
-581.8m THB
Operating Income
71.2m THB
Other Expenses
-44.7m THB
Net Income
26.5m THB

Income Statement
Inter Pharma PCL

Rotate your device to view
Income Statement
Currency: THB
Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
371
N/A
376
+1%
388
+3%
388
+0%
406
+5%
442
+9%
523
+18%
621
+19%
751
+21%
909
+21%
1 003
+10%
1 214
+21%
1 376
+13%
1 523
+11%
1 726
+13%
1 761
+2%
1 797
+2%
1 781
-1%
1 792
+1%
Gross Profit
Cost of Revenue
(157)
(157)
(155)
(154)
(159)
(183)
(239)
(302)
(403)
(508)
(573)
(726)
(826)
(905)
(1 035)
(1 054)
(1 091)
(1 122)
(1 139)
Gross Profit
214
N/A
218
+2%
233
+7%
234
+1%
247
+5%
259
+5%
284
+10%
319
+12%
348
+9%
401
+15%
429
+7%
488
+14%
550
+13%
618
+12%
690
+12%
707
+2%
706
0%
659
-7%
653
-1%
Operating Income
Operating Expenses
(175)
(157)
(154)
(153)
(159)
(182)
(199)
(225)
(244)
(255)
(270)
(327)
(381)
(447)
(499)
(524)
(535)
(550)
(582)
Selling, General & Administrative
(175)
(157)
(156)
(155)
(162)
(187)
(202)
(230)
(253)
(267)
(284)
(339)
(391)
(458)
(512)
(538)
(553)
(568)
(598)
Other Operating Expenses
0
0
2
2
2
5
3
5
9
12
14
13
10
11
13
14
17
18
16
Operating Income
38
N/A
62
+62%
79
+28%
81
+3%
87
+7%
77
-12%
85
+11%
94
+11%
104
+10%
146
+40%
159
+9%
161
+1%
169
+5%
171
+1%
191
+12%
183
-4%
171
-7%
109
-36%
71
-35%
Pre-Tax Income
Interest Income Expense
(1)
(1)
(1)
(1)
(1)
(1)
(2)
(3)
(6)
(8)
(10)
(14)
(19)
(24)
(28)
(29)
(31)
(28)
(26)
Pre-Tax Income
37
N/A
61
+64%
78
+28%
80
+3%
86
+8%
76
-13%
83
+10%
91
+10%
98
+8%
138
+40%
149
+8%
146
-2%
150
+3%
147
-2%
164
+12%
154
-6%
139
-10%
81
-42%
45
-45%
Net Income
Tax Provision
(9)
(14)
(17)
(18)
(19)
(16)
(19)
(22)
(23)
(27)
(28)
(17)
(16)
(19)
(25)
(34)
(34)
(22)
(14)
Income from Continuing Operations
28
47
61
62
68
59
64
69
75
110
121
129
134
127
138
121
105
59
31
Income to Minority Interest
(0)
(4)
(5)
(5)
(6)
(7)
(8)
(6)
(5)
(5)
(6)
(7)
(7)
(8)
(9)
(10)
(11)
(8)
(5)
Net Income (Common)
28
N/A
43
+55%
56
+28%
57
+2%
62
+9%
53
-15%
56
+7%
63
+12%
70
+12%
105
+51%
115
+9%
122
+6%
127
+4%
119
-6%
129
+9%
110
-15%
93
-15%
51
-46%
27
-48%
EPS (Diluted)
0.18
N/A
0.2
+11%
0.19
-5%
0.19
N/A
0.22
+16%
0.18
-18%
0.19
+6%
0.22
+16%
0.24
+9%
0.22
-8%
0.39
+77%
0.41
+5%
0.37
-10%
0.22
-41%
0.34
+55%
0.18
-47%
0.15
-17%
0.08
-47%
0.04
-50%

See Also

Discover More